[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:anaplastic-large-cell-lymphoma":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":122,"states":123},"Anaplastic Large Cell Lymphoma",18,15,[8,16,23,29,36,42,48,54,60,66,72,78,84,90,96,102,109,115],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07001384","A Study of Alectinib and Duvelisib in People With Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma (ALK+ALCL)",[12],"Phase 1","RECRUITING","2026-08-26T02:16:23.080181Z","2026-07-05T03:45:20.025448Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT07013565","Chemoimmunotherapy for ALK+ Relapsed\u002FRefractory ALCL",[20],"Phase 2","2026-08-26T02:15:42.447052Z","2026-05-29T15:36:40.177956Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT06508463","Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma",[12],"2026-08-26T02:18:07.037408Z","2026-07-05T05:32:16.756962Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":34,"content_modified":35},"NCT06724237","Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy",[33],"Phase 3","2026-08-26T02:18:27.904411Z","2026-05-13T02:55:06.567458Z",{"nct_id":37,"title":38,"phases":39,"status":13,"updated_at":40,"content_modified":41},"NCT06615050","A Study of Tacrolimus\u002FMethotrexate\u002FRuxolitinib Versus Post-Transplant Cyclophosphamide\u002FTacrolimus\u002FMycophenolate Mofetil in Non-Myeloablative\u002FReduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)",[33],"2026-08-26T02:16:04.914942Z","2026-07-05T05:32:16.764159Z",{"nct_id":43,"title":44,"phases":45,"status":13,"updated_at":46,"content_modified":47},"NCT07192471","A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma",[12],"2026-08-26T02:17:59.904383Z","2026-07-05T05:32:16.661363Z",{"nct_id":49,"title":50,"phases":51,"status":13,"updated_at":52,"content_modified":53},"NCT03017820","A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma",[12],"2026-08-26T02:19:05.360997Z","2026-06-16T05:54:07.906191Z",{"nct_id":55,"title":56,"phases":57,"status":13,"updated_at":58,"content_modified":59},"NCT05996185","Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell Lymphoma",[20],"2026-08-26T02:16:52.995882Z","2026-05-05T02:43:28.341848Z",{"nct_id":61,"title":62,"phases":63,"status":13,"updated_at":64,"content_modified":65},"NCT04288726","Allogeneic CD30.CAR-EBVSTs in Patients With Relapsed or Refractory CD30-Positive Lymphomas",[12],"2026-08-26T02:16:47.762107Z","2026-05-05T02:43:28.120885Z",{"nct_id":67,"title":68,"phases":69,"status":13,"updated_at":70,"content_modified":71},"NCT05544968","Anti-CD30 biAb-AATC in Patients With Relapsed\u002FRefractory CD30 Positive Hematopoietic Malignancies",[12],"2026-08-26T02:17:20.511551Z","2026-05-05T02:43:27.997953Z",{"nct_id":73,"title":74,"phases":75,"status":13,"updated_at":76,"content_modified":77},"NCT05967416","Study of SIRPant-M in Participants With Relapsed or Refractory Non-Hodgkin's Lymphoma",[12],"2026-08-26T02:15:43.339060Z","2026-05-05T02:43:27.815843Z",{"nct_id":79,"title":80,"phases":81,"status":13,"updated_at":82,"content_modified":83},"NCT07055477","A Phase I Trial Anti-CC Chemokine Receptor 4 Chimeric Antigen Receptor T Cells (CCR4 CAR T Cells) for CCR4 Expressing T-cell Malignancies Including Peripheral T-cell Non-Hodgkin Lymphoma (PTCL) and Cutaneous T-cell Non-Hodgkin Lymphoma (CTCL)",[12],"2026-08-26T02:18:46.137046Z","2026-05-05T02:43:27.673466Z",{"nct_id":85,"title":86,"phases":87,"status":13,"updated_at":88,"content_modified":89},"NCT06176690","Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas",[12],"2026-08-26T02:17:22.153941Z","2026-05-05T02:43:27.308921Z",{"nct_id":91,"title":92,"phases":93,"status":13,"updated_at":94,"content_modified":95},"NCT05010005","A Study of Ruxolitinib and Duvelisib in People With Lymphoma",[12],"2026-08-26T02:16:01.079019Z","2026-05-05T02:43:26.685721Z",{"nct_id":97,"title":98,"phases":99,"status":13,"updated_at":100,"content_modified":101},"NCT05978141","A Registry for People With T-cell Lymphoma",[],"2026-08-26T02:16:20.336282Z","2026-05-13T02:55:06.403613Z",{"nct_id":103,"title":104,"phases":105,"status":106,"updated_at":107,"content_modified":108},"NCT07137481","Phase II Study of CD5 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Aggressive T Cell Hematological Malignancies",[20],"NOT_YET_RECRUITING","2026-08-26T02:19:17.380174Z","2026-05-05T02:43:28.805067Z",{"nct_id":110,"title":111,"phases":112,"status":106,"updated_at":113,"content_modified":114},"NCT07691450","Belinostat in Combination With Azacitidine or Pralatrexate for the Treatment of Relapse or Refractory T-cell Lymphoma",[12],"2026-08-26T02:16:42.787115Z","2026-07-19T19:36:05.157190Z",{"nct_id":116,"title":117,"phases":118,"status":119,"updated_at":120,"content_modified":121},"NCT03690011","Cell Therapy for High Risk T-Cell Malignancies Using CD7-Specific CAR Expressed On Autologous T Cells",[12],"ACTIVE_NOT_RECRUITING","2026-08-03T03:05:09.265674Z","2026-05-05T02:43:27.128098Z",[],[124,128,131,135,139,142,146,149,152,155,158,161,165,168],{"state":125,"count":126,"slug":127},"New York",8,"new-york",{"state":129,"count":126,"slug":130},"Texas","texas",{"state":132,"count":133,"slug":134},"California",6,"california",{"state":136,"count":137,"slug":138},"Florida",5,"florida",{"state":140,"count":137,"slug":141},"New Jersey","new-jersey",{"state":143,"count":144,"slug":145},"Georgia",4,"georgia",{"state":147,"count":144,"slug":148},"Massachusetts","massachusetts",{"state":150,"count":144,"slug":151},"Minnesota","minnesota",{"state":153,"count":144,"slug":154},"Missouri","missouri",{"state":156,"count":144,"slug":157},"Ohio","ohio",{"state":159,"count":144,"slug":160},"Pennsylvania","pennsylvania",{"state":162,"count":163,"slug":164},"Arizona",3,"arizona",{"state":166,"count":163,"slug":167},"Oregon","oregon",{"state":169,"count":163,"slug":170},"Wisconsin","wisconsin"]